Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Unknown 5

Sponsor Class

OTHER 257INDUSTRY 99NIH 24OTHER_GOV 6NETWORK 6UNKNOWN 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 1Thoracic 1Gynecologic 1

Conditions

Triple Negative Breast Neoplasms 3Breast Neoplasms 3

Interventions

Paclitaxel 7Epirubicin 7Capecitabine 7pyrotinib 5Docetaxel 5Carboplatin 5Vinorelbine 4Fulvestrant 4Cyclophosphamide 4exemestane 3anlotinib 3Radiotherapy 3Radiation Dose Hypofractionation 3Etoposide 3pirarubicin 2palbociclib 2apatinib 2Standard of Care 2Neoadjuvant Therapy 2Letrozole 2Albumin-Bound Paclitaxel 2toripalimab 1titanium silicide 1nimotuzumab 1neratinib 1lobaplatin 1liposomal doxorubicin 1icaritin 1eribulin 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
UNKNOWN × Carboplatin × Breast × Clear all
NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT03735082 2018-11-08

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

ChineseAMS

Phase 2 Unknown
29 enrolled
Breast

Breast Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

ChineseAMS

Phase 2 Unknown
200 enrolled
Breast

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

ChineseAMS

Phase 3 Unknown
100 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01276769 2011-11-16

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

ChineseAMS

Phase 2 Unknown
80 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡